Wenxiu Xin

8PUBLICATIONS
8CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 12, 2025
Thromboembolic Risk of Thrombopoietin Receptor Agonists for Adult Primary Immune Thrombocytopenia: A Systematic Review and Meta-Analysis Integrating Randomized Controlled Trials and Prospective Evidence.

Meng-Fei Dai, Gao-Wei Chong, Wen-Xiu Xin

|Apr 02, 2025
miR-135b-5p/PDE3B Axis Regulates Gemcitabine Resistance in Pancreatic Cancer Through Epithelial-Mesenchymal Transition.

Yuxuan Fu, Liangsheng Chen, Neng Lv

|Dec 27, 2024
CAPE activates AMPK and Foxo3 signaling to induce growth inhibition and ferroptosis in triple-negative breast cancer.

Qilu Fang, Qichuan Fang, Rui Cheng

|Jul 13, 2024
Cost-effectiveness analysis of rezvilutamide versus bicalutamide in the treatment of metastatic hormone-sensitive prostate cancer.

Haiying Ding, Shujing Li, Xinglu Xu

|May 18, 2024
Safety and hematological toxicities of PARP inhibitors in patients with cancer: a systematic review of randomized controlled trials and a pharmacovigilance analysis.

Meng-Fei Dai, Xin Wang, Wen-Xiu Xin

|Mar 08, 2023
ASPM promotes migration and invasion of anaplastic thyroid carcinoma by stabilizing KIF11.

Qilu Fang, Qinglin Li, Yajun Qi

Pageof 2

Frequent Collaborators

1 joint publications

Meng-Fei Dai

1 joint publications

Gao-Wei Chong

1 joint publications

Hai-Ying Ding

1 joint publications

Yinghui Tong